Izinzuzo zezeMpilo, iziSebenzi, iimpembelelo zecala kunye nokunye
Kwimichiza yemfuyo, into ebonakalayo njenge-nigella sativa ngamanye amaxesha isetyenziswa ukunyanga iimeko ezithile zempilo. Kwakhona kuthiwa imbewu emnyama, i-cumin emnyama kunye neentyantyambo ze-fennel, i-nigella sativa ikhula kulo lonke elaseIndiya, i-Arabia, ne-Yurophu kwaye sele isetyenziswe njenge-spices kunye nokulondoloza ukutya. Ngoxa uphando olwenziwe kwimiphumo yezempilo yase-nigella sativa lucacisiwe, ukufunyaniswa kwezifundo zezilwanyana kubonisa ukuba i-nigella sativa inokunikela ngeenzuzo zokukhusela umzimba kunye ne-antioxidant.
Ukusetyenziswa kweNigella Sativa
I-Nigella sativa ngokuqhelekileyo isetyenziswe njengesiluleko semvelo kwezi ngxaki zempilo:
Inzululwazi ilandele iNigella Sativa
Kuza kubekho, kunqongophala kokuhlolwa kovavanyo lweeklinikhi zakwa-nigella sativa. Nangona kunjalo, uphando olukhoyo lubonisa ukuba i-nigella sativa inamathela kwisithembiso kwonyango kunye / okanye ukukhuselwa kwezi zilandelayo:
1) I-asthma
I-Nigella sativa inokunceda ukuphucula iimpawu zesifo se-asthma, ngokutsho kwincwadana encinci epapashwe ngo-2007. Kwiinyanga ezintathu, abantu abadala abangama-29 abane-asthma bathatha i-placebo okanye i-nigella sativa yocatshulwa imihla ngemihla. Iziphumo zokufunda zibonisa ukuba abo baphathwa nge-nigella sativa babenokuphuculwa kancinci kwimeko kunye nobuqhamo beempawu ze- asthma (ezifana nokuvutha).
2) Uxinzelelo lwegazi oluphezulu
Kwisifundo esincinci esashicilelwe ngo-2008, abaphandi bafumanisa ukuba i-nigella sativa inokukunceda ukugcina uxinzelelo lwegazi kuhlolwe.
Emva kweeveki ezisibhozo zonyango-unyango lwe-nigella sativa nsuku zonke, izigulane ezinexinzelelo lwengcinezelo zinobuncipheko obuninzi kwixinzelelo legazi (xa kuthelekiswa nalabo abelwe isongezelelo se-placebo).
3) ICancretic Cancer
Iziphumo ezivela kuphando lwe-tube-test zibonisa ukuba i-nigella sativa inokukunceda ukukhusela umhlaza we- pancreatic .
Kuluhlu lweemvavanyo zebhu, izazi zenzululwazi zifumene ukuba i-thymoquinone (igosa eliyinhloko lika-nigella sativa ioli) yanciphisa kakhulu amanqanaba e-pro-inflammatory compounds afunyanwe kwiimvumba ze-pancreatic.
Imijelo
Uvavanyo kwizilwanyana lubonisa ukuba amayeza aphezulu e-nigella sativa angonakalisa iinjongo kunye / okanye isibindi. Okona, ukuthatha i-nigella sativa ngelixa i- chemotherapy ingabangela ukuba iziphumo zamachiza e-chemotherapy zichaphazeleke.
Izibonelelo azange zivavanywe ukhuseleko kwaye ngenxa yokuba izongezo zokutya zikhululekile kakhulu, umxholo weemveliso ezithile zingahluka kwizinto ezichaziweyo kwilebula yomkhiqizo. Kwakhona ugcine ukhumbule ukuba ukhuseleko lwezongezelelo kwabasetyhini abakhulelweyo, oomama abangabongikazi, abantwana kunye nalabo abanezifo zonyango okanye abo bathabatha imishanguzo ayilwanga. Unokufumana iingcebiso ekusebenziseni izongezo kodwa ukuba ucinga ngokusetyenziswa kwezigulane ze-nigella sativa, khuluma nomboneleli wakho oyintloko wokunakekela. Ukuziphathela imeko kunye nokuphepha okanye ukulibazisa ukunakekelwa okuqhelekileyo kunokuba nemiphumo emibi.
Ukusebenzisa iNigella Sativa yezeMpilo
Ngenxa yokungabikho kwenkxaso yesayensi ngemiphumo yempilo yayo, kungekudala ukuba kunconywe i-nigella sativa njengonyango oluqhelekileyo unyango kwanoma yimuphi umqathango.
Ukuba ucinga ngokusetyenziswa kwe-nigella sativa unyango okanye ukukhusela ingxaki ethile yempilo, qiniseka ukuba udibane nodokotela wakho ngaphambi kokuba uqale irejimen yakho yokuncedisa.
> Imithombo:
> Ali BH, Blunden G. "Impahla ye-Pharmacological and Toxicological yaseNigella Sativa." I-Phytother Res. 2003 17 (4): 299-305.
> Boskabady MH, uJavan H, uSajady M, uRakhshandeh H. "I-Prophylactic Impact of Impact of Nigella Sativa Seed Extract in Patient Patients." IFomdam Clinic Pharmacol. 2007 21 (5): 559-66.
> Chehl N, Chipitsyna G, Gong Q, Yeo CJ, uArafat HA. Iimpembelelo ezichasene neNigella Sativa Seed Extract, Thymoquinone, kwiiseli zeCancreatic Cancer. "I-HPB (Oxford). 2009 11 (5): 373-81.
> Dehkordi FR, Kamkhah AF. I-Impact Anti-Impact of Nigella Sativa Seed Extract in Patients With Hypertension. "I-Fundam Clinic Pharmacol. 2008 22 (4): 447-52.